INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

INOINOVIO PHARMACEUTICALS, INC.

CIK 0001055726

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 0
Max Insider Score21
Connections2with evidence

INO · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Grant or award
A—
46.9K sh
May 20, 2026May 21, 2026
traded May 20, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Sumner Michael JohnChief Medical Officer · Mar 5, 2026
13
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Tax withholding
F
$3,312
2,693 sh
May 20, 2026
May 21, 2026
traded May 20, 2026
+1d
SEC FORM 4

Evidence

21
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Option exercise
M—
9,450 sh
May 20, 2026May 21, 2026
traded May 20, 2026
+1dSEC FORM 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Grant or award
A—
37.7K sh
May 20, 2026May 21, 2026
traded May 20, 2026
+1dSEC FORM 4

Evidence

17
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Option exercise
M—
9,450 sh
May 20, 2026May 21, 2026
traded May 20, 2026
+1dSEC FORM 4

Evidence

13
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Option exercise
M—
4,292 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Tax withholding
F$2,128
1,223 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Option exercise
M—
4,292 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Grant or award
A—
36.8K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence

9
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Grant or award
A—
29.6K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC FORM 4

Evidence